Emeryville, California-based Metagenomi, Inc., a precision genetic medicines company developing curative therapeutics using its proprietary, metagenomics-derived genome editing toolbox, has priced initial public offering of 6.25 million shares of common stock at $15.00 per share.
Metagenomi shares will begin trading on the Nasdaq today, under the symbol MGX.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.